Gout

Hyperuricemia and gout in cardiovascular, metabolic and kidney disease

Hyperuricemia and gout in cardiovascular, metabolic and kidney disease

Authors: Claudio Borghi, Enrico Agabiti-Rosei, Richard J. Johnson, Jan T. Kielstein,Empar Lurbe, Giuseppe Mancia, Josep Redon, Austin G. Stack, Konstantinos P. Tsioufis. Highlights: Increasing prevalence of hyperuricaemia has been noted in many populations.

Continue Reading
Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality

Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality

Authors: Fernando Pérez Ruiz, Pascal Richette, Austin G Stack, Ravichandra Karra Gurunath, Ma Jesus García de Yébenes Loreto Carmona Abstract Objective: To determine the impact of achieving serum uric acid (sUA) of <0.

Continue Reading
Prevalence and Treatment of Gout among Patients with Chronic Kidney Disease in the Irish Health System: A National Study

Prevalence and Treatment of Gout among Patients with Chronic Kidney Disease in the Irish Health System: A National Study

Authors: Mohammed E, Browne LD, Kumar A U A, Adeeb F, Fraser AD, Stack AG. Abstract BACKGROUND: Gout is a common inflammatory arthritis associated with adverse clinical outcomes.

Continue Reading
Gout and the Risk of Advanced Chronic Kidney Disease in the UK Health System: A National Cohort Study

Gout and the Risk of Advanced Chronic Kidney Disease in the UK Health System: A National Cohort Study

Authors: Stack, Austin Johnson, Michelle Blak, Betina Klein, Alyssa Carpenter, Lewis Morlock, Robert Maguire, Andrew Parsons, Victoria. Abstract OBJECTIVE: Evaluate association of gout with progression to advanced CKD in a national study.

Continue Reading